The disclosure relates to medical graft devices comprising an extracellular matrix having regions of differing properties.
Medical graft devices made from dried sheets of bioabsorbable tissue comprising an extracellular matrix (ECM) can serve as tissue grafts and in wound healing applications. Common methods of preparing ECM-based collagenous tissues for use as medical graft devices include vacuum pressing and lyophilization (freeze drying). Both methods produce sheets of ECM tissue having differing properties, such as degree of porosity or of compression of the matrix structure.
For example, vacuum pressing comprises compressing hydrated, remoldable material while subjecting the material to a vacuum. Tissue compressed by vacuum pressing generally has a higher tensile strength and lower strain value compared to tissue compressed by other methods because of its more compressed matrix structure. Vacuum pressing can also laminate multiple layers of ECM material together by crushing the matrix structure of the ECM. Lyophilization, on the other hand, comprises drying tissue by sublimation, a process of changing ice crystals from a solid directly to a gas without passing through an intermediate liquid phase. During lyophilization, a vacuum applied to frozen tissue at low temperatures causes the ice crystals to sublimate from the frozen tissue, leaving behind small pockets of open space formerly occupied by the ice. Hence, the resultant dried tissue has a more open matrix structure compared to tissue dried by other methods due to pores created in the frozen tissue after extraction of the ice crystals. Surgeons often use lyophilized devices for wound management since their open matrix structure results in a faster resorption time and their open spaces allow for increased integration and interaction with local cells and tissue.
Problematically, with the traditional lyophilization process, the size and thickness of the underlying tissue source (for example, intestinal tissue) typically limits the size and thickness of sheets of ECM available for use as medical graft device. The lyophilization process alone does not create lamination between tissue layers that allow for the creation of devices larger than the area of a single piece of tissue alone. Hence, a typical sheet produced from the UBM ECM source may be no larger than 10×15 cm after processing as a single UBM sheet does not typically exceed the 10×15 cm area, meaning that a surgeon may need to use multiple sheets to apply to a large wound area. Furthermore, the surgeon may need to apply several layers of the sheets to achieve a desired thickness. Therefore, a need exists for larger area and/or thicker lyophilized medical graft devices. However, as introduced above, lyophilization alone cannot produce such ECM devices, since lyophilization does not laminate layers of tissue together with a high enough lamination strength for viable devices. Thus, a continuing need exists for large-area medical graft devices having the open-matrix structure of a lyophilized device and method of creation.
The present disclosure describes large-area medical graft devices comprising at least two sheets of planar biological material, such as extracellular matrix material (ECM). The sheets of ECM have overlapping regions that are compressed together during a non-drying process, and other overlapping regions that are not compressed together. Once the appropriate overlapping regions of the sheets are compressed together, the entire device is lyophilized to bond the compressed regions together, resulting in the compressed overlapping regions having a more collapsed matrix structure and the non-compressed overlapping regions having a more open matrix structure. Advantageously, the sheets can have a stacked orientation to create a desired thickness, or a staggered orientation to create a desired surface area. The sheets can also have combinations of both a stacked and a staggered orientation to create both a desired surface area and thickness.
In examples, medical graft devices of the disclosure include at least two sheets of extracellular matrix material (ECM) having at least one first overlapping region that is compressed together during a non-drying method, and at least one second overlapping region that is not compressed together. The at least one second overlapping region has a more open matrix structure than the at least one first overlapping region. The compressed at least one first overlapping region is bonded together during a drying method.
In further examples, the at least two sheets of ECM are at least three sheets of ECM. In examples, the at least two sheets of ECM are configured in a stacked orientation or in a staggered orientation. In examples, the staggered orientation comprises at least a first layer of the at least two sheets of ECM, and at least a second layer of the at least two sheets of ECM is offset from the first layer. In examples, the ECM is synthetic or naturally-occurring. In examples, the at least one first overlapping region extends around a periphery of the device and at least partially defines the at least one second overlapping region. In examples, the at least one first overlapping region has a cross-bar configuration and at least partially defines the at least one second overlapping region. In examples, the medical graft device is a tissue graft. In other examples, the medical graft device is a wound dressing device.
Examples of a method of making a medical graft device of this disclosure include preparing at least two hydrated sheets of extracellular matrix material (ECM). Regions of the at least two hydrated sheets are then compressed without drying. The at least two hydrated sheets are then frozen to bond together the compressed regions of the at least two hydrated sheets. Non-compressed regions of the at least two dehydrated sheets have a more open matrix structure than the compressed regions of the at least two dehydrated sheets.
In further examples, preparing the at least two hydrated sheets includes securing the at least two hydrated sheets to a first support structure having at least one open area defined by a semi-solid area, and placing a second support structure over the at least two hydrated sheets. The second support structure has an identical geometry to the first support structure. The second support structure is placed over the at least two hydrated sheets such that at least one open area and a semi-solid area of the second support structure aligns with the at least one open area and the semi-solid area of the first support structure. In examples, compressing the regions of the at least two hydrated sheets includes compressing regions of the at least two hydrated sheets in contact with the semi-solid areas of the first and second support structures. In examples, the at least two hydrated sheets are secured to the first support structure in a stacked orientation or in a staggered orientation. In examples, securing the at least two hydrated sheets to the first support structure includes securing the at least two hydrated sheets to securing elements disposed about an outer edge of the first support structure. In examples, after dehydrating the at least two hydrated sheets, the second support structure is removed from the at least two sheets. In examples, after dehydrating the at least two hydrated sheets, the at least two dehydrated sheets are removed from the first support structure. In examples, securing the at least two hydrated sheets to the first support structure includes securing at least a first one of the at least two hydrated sheets to the first support structure in a first layer, securing at least a second one of the at least two hydrated sheets to the first support structure in a second layer offset from the first layer, and securing at least a third one of the at least two hydrated sheets to the first support structure in a third layer aligned with the first layer.
In examples, the medical graft devices of this disclosure also include medical graft devices produced by preparing at least two hydrated sheets of extracellular matrix material (ECM), compressing regions of the at least two hydrated sheets without drying, and freezing the at least two hydrated sheets to bond together the compressed regions of the at least two hydrated sheets. Non-compressed regions of the at least two dehydrated sheets have a more open matrix structure than the compressed regions of the at least two dehydrated sheets.
A reading of the following detailed description and a review of the associated drawings will make apparent the advantages of these and other features. Both the foregoing general description and the following detailed description serve to explain the disclosure only and do not restrict aspects of the disclosure as claimed.
Reference to the detailed description, in conjunction with the following figures, will make the disclosure more fully understood, wherein:
In the description that follows, like components have the same reference numerals, regardless of whether they are present in different examples. To illustrate examples in a clear and concise manner, the drawings may not necessarily illustrate scale and may show certain features in somewhat schematic form. Features described and/or illustrated with respect to one example may exist in the same way or in a similar way in one or more other examples and/or in combination with or instead of the features of the other examples.
As used in the specification and claims, for the purposes of describing and defining the invention, the terms “about” and “substantially” represent the inherent degree of uncertainty attributed to any quantitative comparison, value, measurement, or other representation. The terms “about” and “substantially” also represent the degree by which a quantitative representation may vary from a stated reference without resulting in a change in the basic function of the subject matter at issue. “Comprise,” “include,” “have,” and variations of each word include the listed parts and can include additional parts not listed. “And/or” includes one or more of the listed parts and combinations of the listed parts. The terms “upper,” “lower,” “above,” “below,” and the like serve to clearly describe the disclosure but do not limit the structure, positioning and/or operation of the disclosure in any manner. As used in the specification and claims, the term “laminate” describes both the process and the end result of two or more independent pieces of tissue bonding together. Thus, lamination produces a directed area of connection between the tissues that would not occur unless intentionally created.
The device 10 had laminated regions 12 of compressed tissue with a collapsed matrix structure, and non-laminated regions 14 of uncompressed tissue that preserves the native matrix structure. The device 10 thus advantageously combines the laminated properties of multi-layer tissue produced by vacuum pressing with the open matrix structure of lyophilized tissue.
As shown in
Turning now to
As shown in
In the methods of the present disclosure, which may be referred to as lyophilization compression methods, the compressed matrix structure is a result of the compression of the porous boards during the tissue compression step 22. This compression can be achieved through the use of the vacuum sealing in a bag or clamps as illustrated in the drawings and described above, or other means of pressing the boards together. As illustrated in
The medical graft device 10 can be used, for example, as a tissue graft or wound dressing device, or to create a pouch structure for encasing an implantable electronic device.
One skilled in the art will realize the disclosure may embody other specific forms without departing from the spirit or essential characteristics thereof. The foregoing examples in all respects illustrate rather than limit the disclosure described herein. The appended claims, rather than the foregoing description, thus indicate the scope of the disclosure, and embrace all changes that come within the meaning and range of equivalency of the claims.
This application claims priority to and benefit under 35 U.S.C. 119(e) to U.S. Provisional Application No. 63/131,559, filed Dec. 29, 2020, the entire contents of which are incorporated by reference herein.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/064119 | 12/17/2021 | WO |
Number | Date | Country | |
---|---|---|---|
63131559 | Dec 2020 | US |